Home/Filings/4/0001144204-08-036891
4//SEC Filing

RxElite, Inc. 4

Accession 0001144204-08-036891

CIK 0001346405operating

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 3:31 PM ET

Size

7.9 KB

Accession

0001144204-08-036891

Insider Transaction Report

Form 4
Period: 2008-05-02
Sullivan Earl
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2008-05-02+450,000450,000 total
    Exercise: $0.28Exp: 2013-05-02Common Stock (450,000 underlying)
  • Award

    Stock Option (Right to buy)

    2008-05-02+750,000750,000 total
    Exercise: $0.28Exp: 2018-05-02Common Stock (750,000 underlying)
Footnotes (2)
  • [F1]These options were granted pursuant to the 2007 Incentive Stock Plan which is subject to stockholder approval.
  • [F2]All of the options are subject to vesting and vest in 25% increments beginning on May 2, 2009.

Documents

1 file

Issuer

RxElite, Inc.

CIK 0001346405

Entity typeoperating

Related Parties

1
  • filerCIK 0001346405

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 3:31 PM ET
Size
7.9 KB